Brazil to use US medtech code to strengthen ethical interactions with HCPs
This article was originally published in SRA
Three Brazilian medical device industry associations look set to bring their country's practices for ethical interactions between companies and healthcare providers (HCPs) into line with those advocated by US medtech trade group AdvaMed1.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.